Previous Close
$7.94
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$380.2 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and ...
Community
- 0 posts discussing
0
Watchers
0
Visitors